Krishnan Rajagopalan

Venture Capital Advisor @Dallas Venture Capital

Edison, NJ, US
MOBILE NUMBERS
+91 *********19

Signup · Get unlimited contacts

WORK HISTORY

Feb 2022 — Present

Venture Capital Advisor @Dallas Venture Capital

View department →

NJ, US

o Dallas Venture Capital (DVC) is an early-stage venture capital firm focused mainly on US and India based technology companies. Focus areas include cloud infrastructure, AI, IoT, XR, and other emerging technologies launched by enterprise-focused entrepreneurs. o As an advisor, my primary focus is on the Healthcare / Life Sciences technology and services areas. I am actively involved in the identification of appropriate early-stage companies, evaluation of market and growth opportunities, and helping them scale and grow.

EDUCATION

1989 — 1994

University of Kentucky

Doctor of Philosophy (Ph.D.), Bio organic chemistry

1998 — 1999

Harvard Medical School

Postgraduate Degree, Cancer research

ABOUT KRISHNAN RAJAGOPALAN

Dr. Krishnan Rajagopalan has more than 30 years’ experience in AI-led digital and business transformation, Value Creation and rapid growth across Global IT, Business Process Services, Business and digital transformation and SaaS products & services with a deep healthcare / life sciences focus. He has led Fortune 500 companies and strategic business units from start-up mode to a Tier 1 status (e.g,$150 MM revenue and global staff) across R&D, Clinical Operations, Clinical Data Sciences (CDM, Biostats, Medical Writing), Pharmacovigilance, regulatory affairs, commercial operations and other areas. Krishnan is currently the President of Life Sciences - Strategic Advisory and Consultancy Services (LS-SACS.com) that provides customized and outcomes-based consulting services to pharma, biotech and medical device companies on growth strategy, business and AI driven digital transformation, future operating models, leadership build, organizational change (OCM) and strategic sourcing / outsourcing. He also advises PE / VC firms on evaluation of assets in HC / LS, SaaS, IT and global services and digital product companies on their strategy and GTM approaches. His leadership roles include Mitchell Madison Group, PA Consulting, Infosys, Cognizant and Navitas Life Sciences. Krishnan was a National Cancer Institute Fellow at the Harvard Medical School and Massachusetts General Hospital. He has a Ph. D, in bio-organic Chemistry from the University of Kentucky and has more than 20 publications, presentations and a US Patent.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Krishnan Rajagopalan — Venture Capital Advisor at Dallas Venture Capital in Edison, NJ, US | Unifers